About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Pancreatic Cancer Clinical Trials in Seattle | 192 Studies

Clinical Trials Pancreatic CancerSeattle

Pancreatic Cancer Clinical Trials in Seattle

Find 192 clinical trials for pancreatic cancer near Seattle, Washington. Connect with research centers in your area.

All Pancreatic Cancer trials nationwide All trials in Seattle

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 41-60 of 192 trials

Active not recruitingTargeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)This phase II MATCH screening and multi-sub-trial studies how well treatment that is directed by genetic testing works in patients with solid tumors, lymphomas, or multiple…NCT02465060·Birmingham, Alabama and 1409 others

Pancreatic Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedA Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid TumorsThis clinical trial is an interventional, active-treatment, open-label, multi-center, Phase 1/2 study.NCT03997968·San Francisco, California and 15 others

RecruitingA Study of Sigvotatug Vedotin in Advanced Solid TumorsThis trial will look at a drug called sigvotatug vedotin (SGN-B6A) alone and with pembrolizumab, with or without chemotherapy, to find out whether it is safe for people who have…NCT04389632·Anchorage, Alaska and 157 others

UnknownPANVAC™-VF Vaccine for the Treatment of Metastatic Pancreatic Cancer After Failing a Gemcitabine-Containing RegimenThe objectives of this multi-center, randomized, controlled trial are to evaluate the safety and efficacy of PANVAC-VF in combination with Granulocyte-macrophage…NCT00088660·Mobile, Alabama and 61 others

CompletedBMS-247550 in Treating Patients With Advanced Pancreatic CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00016965·Mobile, Alabama and 94 others

RecruitingA Study of MRG007 (ARR-217) in Patients With Advanced Solid TumorsThis is an open-label, multi-center, phase I study to evaluate the safety, tolerability, efficacy, and pharmacokinetics of MRG007 (ARR-217) in patients with unresectable locally…NCT07066657·Los Angeles, California and 20 others

CompletedPerioperative Therapy for Resectable Pancreatic CancerThis phase II trial studies how well giving combination chemotherapy together with intensity-modulated radiation therapy (IMRT) and surgery works in treating patients with…NCT00609336·Seattle, Washington

CompletedEvaluation of Efficacy and Safety of Neoadjuvant Treatment With Pamrevlumab in Combination With Chemotherapy (Either Gemcitabine Plus Nab-paclitaxel or FOLFIRINOX) in Participants With Locally Advanced, Unresectable Pancreatic CancerThis is a Phase 3, randomized, double-blind trial to evaluate the efficacy and safety of neoadjuvant treatment with pamrevlumab or placebo in combination with either gemcitabine…NCT03941093·Phoenix, Arizona and 89 others

CompletedA Study in Metastatic Cancer and Advanced or Metastatic Unresectable Pancreatic CancerPhase 1b: To determine the safe and tolerable dose of galunisertib in combination with gemcitabine in patients with solid malignancy Phase 2a: To compare the overall survival…NCT01373164·Tampa, Florida and 23 others

Active not recruitingColorectal Cancer Screening in Cystic FibrosisThis multi-center study will compare multi-target DNA and quantitative FIT stool-based testing to colonoscopy in individuals with Cystic Fibrosis (CF) undergoing colon cancer…NCT05362344·Los Angeles, California and 25 others

UnknownAlternative Neoadjuvant Chemotherapy in Resectable and Borderline Resectable Pancreatic CancerUsing alternative neoadjuvant gemcitabine-nab-paclitaxel and nal-IRI with 5-Fluorouracil (5FU) and folinic acid (Leucovorin) regimens of localized cancer, we hope to ensure…NCT03703063·Seattle, Washington

Active not recruitingClaudin 18.2-Targeted Chimeric Antigen Receptor T-cells in Subjects With Unresectable, Locally Advanced, or Metastatic Gastric, Gastroesophageal Junction (GEJ), Esophageal, or Pancreatic AdenocarcinomaThis is a Phase 1, Open-Label, Dose Escalation and Expansion, Multicenter Study of Claudin 18.2-Targeted Chimeric Antigen Receptor T-cells in Subjects with Unresectable, Locally…NCT05539430·Tampa, Florida and 8 others

Active not recruitingStudy of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Metastatic Pancreatic Ductal AdenocarcinomaThe purpose of this study is to compare overall survival of quemliclustat, nab-paclitaxel and gemcitabine versus placebo, nab-paclitaxel and gemcitabine in all randomized patients.NCT06608927·Phoenix, Arizona and 110 others

CompletedFOLFIRI or Modified FOLFIRI and Veliparib as Second Line Therapy in Treating Patients With Metastatic Pancreatic CancerThis randomized phase II trial studies how well modified irinotecan hydrochloride, leucovorin calcium, fluorouracil (FOLFIRI) and veliparib as a second line of therapy work…NCT02890355·Mobile, Alabama and 782 others

Active not recruitingEfficacy and Safety Study of Tisotumab Vedotin for Patients With Solid TumorsThis trial will study tisotumab vedotin to find out whether it is an effective treatment alone or with other anticancer drugs for certain solid tumors and what side effects…NCT03485209·Encinitas, California and 174 others

RecruitingA Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H MutationPhase 1 dose escalation and expansion study of CLSP-1025, a first-in-class HLA-A\*02:01 specific T cell engager (TCE) targeting solid tumors that harbor the p53 R175H mutation.NCT06778863·Scottsdale, Arizona and 20 others

TerminatedPhase II Study to Evaluate Efficacy and Safety of RP101 in Combination With GemcitabineThis will be a Phase II, multicenter, randomized, double blind, placebo controlled, study of six 28-day treatment cycles for patients with locally advanced, unresectable, or…NCT00550004·Tucson, Arizona and 54 others

CompletedRegorafenib in Treating Patients With Advanced or Metastatic Neuroendocrine TumorsThis phase II trial studies regorafenib in treating patients with neuroendocrine tumors that have spread from the primary site (place where it started) to other places in the body.NCT02259725·Scottsdale, Arizona and 4 others

TerminatedPhase 2b Study of GC4711 in Combination With SBRT for Nonmetastatic Pancreatic CancerGTI-4711-201 is designed as a Phase 2b, multicenter, randomized, double-blind, placebo-controlled study to determine the effect to OS by adding GC4711 to SBRT following…NCT04698915·Gilbert, Arizona and 34 others

CompletedThe Canadian/US Integrative Oncology StudyThis study describes the survival outcomes of advanced stage breast, colorectal, ovarian and pancreatic cancer patients receiving advanced integrative oncology (AIO) treatment at…NCT02494037·Scottsdale, Arizona and 11 others

PreviousPage 3 of 10Next

Other Conditions in Seattle

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia